Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral cladribine and fingolimod for relapsing multiple sclerosis.

Literature DB >> 20445188

Oral cladribine and fingolimod for relapsing multiple sclerosis.

Howard Mann.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2010 PMID： 20445188 DOI： 10.1056/NEJMc1002550

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

Review 1. Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors: Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal: Surv Ophthalmol Date: 2013-09-05 Impact factor: 6.048

2. Expression of leukotriene B₄ receptor 1 defines functionally distinct DCs that control allergic skin inflammation.

Authors: Tomoaki Koga; Fumiyuki Sasaki; Kazuko Saeki; Soken Tsuchiya; Toshiaki Okuno; Mai Ohba; Takako Ichiki; Satoshi Iwamoto; Hirotsugu Uzawa; Keiko Kitajima; Chikara Meno; Eri Nakamura; Norihiro Tada; Yoshinori Fukui; Junichi Kikuta; Masaru Ishii; Yukihiko Sugimoto; Mitsuyoshi Nakao; Takehiko Yokomizo
Journal: Cell Mol Immunol Date: 2020-10-09 Impact factor: 11.530

2 in total

Oral cladribine and fingolimod for relapsing multiple sclerosis.

Review 1. Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

2. Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation.

2. Expression of leukotriene B₄ receptor 1 defines functionally distinct DCs that control allergic skin inflammation.